Skip to main content

Advertisement

SpringerLink
Log in

Successful Use of Octreotide to Treat Ménétrier’s Disease: A Rare Cause of Abdominal Pain, Weight Loss, Edema, and Hypoalbuminemia

  • Stanford Multidisciplinary Seminars
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Gadour MO, Salman AH, El Samman el Tel W, et al. Ménétrier’s disease: an excellent response to octreotide. A case report from the Middle East. Trop Gastroenterol. 2005;26:129–131.

    PubMed  Google Scholar 

  2. Green BT, Branch MS. Ménétrier’s disease treated with octreotide long-acting release. Gastrointest Endosc. 2004;60:1028–1029. doi: 10.1016/S0016-5107(04)02215-1.

    Article  PubMed  Google Scholar 

  3. Yeaton P, Frierson HF Jr. Octreotide reduces enteral protein losses in Ménétrier’s disease. Am J Gastroenterol. 1993;88:95–98.

    PubMed  CAS  Google Scholar 

  4. Coffey RJ, Washington MK, Corless CL, et al. Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach. J Clin Invest. 2007;117:70–80. doi: 10.1172/JCI30491.

    Article  PubMed  CAS  Google Scholar 

  5. Lee EL, Feldman M. Gastritis and gastropathies. In: Feldman M, Friedman LS, eds. Sleisenger & Fordtran’s Gastrointestinal and Liver Disease, 8th edn. Philadelphia: Saunders; 2006:1068–1088.

    Google Scholar 

  6. Bluth RF, Carpenter HA, Pittelkow MR, et al. Immunolocalization of transforming growth factor-alpha in normal and diseased human gastric mucosa. Hum Pathol. 1995;26:1333–1340. doi: 10.1016/0046-8177(95)90298-8.

    Article  PubMed  CAS  Google Scholar 

  7. Dempsey PJ, Goldenring JR, Soroka CJ, et al. Possible role of transforming growth factor alpha in the pathogenesis of Ménétrier’s disease: supportive evidence form humans and transgenic mice. Gastroenterology. 1992;103:1950–1963.

    PubMed  CAS  Google Scholar 

  8. Takagi H, Jhappan C, Sharp R, et al. Hypertrophic gastropathy resembling Ménétrier’s disease in transgenic mice overexpressing transforming growth factor alpha in the stomach. J Clin Invest. 1992;90:1161–1167. doi: 10.1172/JCI115936.

    Article  PubMed  CAS  Google Scholar 

  9. Pinski J, Halmos G, Schally AV. Somatostatin analog RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of androgen-independent DU-145 human prostate cancer line in nude mice. Cancer Lett. 1993;71:189–196. doi: 10.1016/0304-3835(93)90115-P.

    Article  PubMed  CAS  Google Scholar 

  10. Lahlou H, Guillermet J, Hortala M, et al. Molecular signaling of somatostatin receptors. Ann N Y Acad Sci. 2004;1014:121–131. doi: 10.1196/annals.1294.012.

    Article  PubMed  CAS  Google Scholar 

  11. Watt HL, Kharmate GD, Kumar U. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells. Cell Signal. 2009;21:428–439.

    Article  PubMed  CAS  Google Scholar 

  12. Burdick JS, Chung E, Tanner G, et al. Treatment of Ménétrier’s disease with a monoclonal antibody against the epidermal growth factor receptor. N Engl J Med. 2000;343:1697–1701. doi: 10.1056/NEJM200012073432305.

    Article  PubMed  CAS  Google Scholar 

  13. Hardie WD, Davidson C, Ikegami M, et al. EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2008;294:L1217–L1225. doi: 10.1152/ajplung.00020.2008.

    Article  PubMed  CAS  Google Scholar 

  14. Settle SH, Washington K, Lind C, et al. Chronic treatment of Ménétrier’s disease with Erbitux: clinical efficacy and insight into pathophysiology. Clin Gastroenterol Hepatol. 2005;3:654–659. doi: 10.1016/S1542-3565(05)00368-X.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Stanford University Medical Center, 300 Pasteur Drive, MC: 5187, Stanford, CA, 94305-5187, USA

    Michael Rothenberg

  2. Department of Pathology and Laboratory Medicine, Stanford University Medical Center, Stanford, CA, USA

    Reetesh Pai

  3. 9460 North Name Uno, Gilroy, CA, 95020, USA

    Kevin Stuart

Authors
  1. Michael Rothenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Reetesh Pai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kevin Stuart
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael Rothenberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rothenberg, M., Pai, R. & Stuart, K. Successful Use of Octreotide to Treat Ménétrier’s Disease: A Rare Cause of Abdominal Pain, Weight Loss, Edema, and Hypoalbuminemia. Dig Dis Sci 54, 1403–1407 (2009). https://doi.org/10.1007/s10620-009-0754-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-009-0754-z

Keywords

Search

Navigation